Jennifer Tousignant

Chief Legal Officer, Viridian Therapeutics, Inc.\DE

Bought, 12 months

$0.0M

Sold, 12 months

$0.4M

Companies

Latest trade

Aug 19, 2026

Companies

Viridian Therapeutics, Inc.\DEChief Legal Officer −$0.4M

Trades

VRDN Sold 14,212 shares at $24.50 $0.3M Aug 19

VRDN Sold 2,272 shares at $31.16 $0.1M Dec 31

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.